Alira Health

Alira Health

Alira Health Contributes to 2021 Bioregion Report on the Future of Catalan Life Sciences

Provides Key Trends in Market Access for Pharma and MedTech

Published on:
January 27, 2022


January 27, 2022 – Alira Health, a global healthcare consulting and technology firm, announced that it is a key contributor to the just released 2021 Bioregion Report, the benchmark study that analyzes the life sciences and healthcare sector in Catalonia, conducted by Biocat, BioRegion of Catalonia together with CataloniaBio & HealthTech and ACCIÓ. Alira Health provided an in-depth analysis of market access trends, as well as tools to help understand the phases of market access in different countries, highlighting ways to ensure that the adoption of products (drugs, medical devices) is most effective.

Some key findings from the report –

  • Health startups in the BioRegion raised €238 million in 2021, a new record.
  • Venture capital remains the main source of investment, up 34% from 2020. 83% of the venture capital raised was from international investors.
  • The medical technology subsector attracted the most investment while digital health companies saw investment nearly double from 2020.

This report was promoted by Biocat, CataloniaBio & HealthTech and ACCIÓ on January 25th at an event featuring the President of the Government of Catalonia and representatives from the sector.

Chus Castillo

Chus Castillo Gutierrez

Director of Global Market Access at Alira Health

“We are extremely pleased to contribute to this important annual report on the growth drivers and opportunities in the Catalan life sciences and health care ecosystem,” said Chus Castillo Gutierrez, Director of Global Market Access at Alira Health. “Alira Health has a very strong presence in Catalonia, with over 90 employees in our Barcelona office. We are deeply committed to supporting the growth and transformation of healthcare in Spain. This forward-looking report is an essential read for every healthcare organization who aspires to be a strong player in Catalonia as the region positions itself to be a leading European hub for emerging therapies and personalized medicine.”

About Alira Health

Alira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare. We work with healthcare and life sciences organizations looking for support across their entire solutions lifecycle. From development to medical care, we complement our clients’ expertise with a full spectrum of services including research and clinical development solutions, technology-powered consulting, and real-world evidence.
Our integrated and multidisciplinary team of over 500 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50% of MedTech companies and 75% of the top 50% of Pharma companies.

Related news

Articles March 18, 2024
WHO Model Lists of Essential Medicines: What You Need to Know 
Our Market Access experts share the importance of the EML for pharma companies and four best practices for a successful application, based on our extensive experience in interactions with the WHO.
Market Access
Events February 20, 2024
World EPA Congress Europe
Look for market access and pricing experts Ahmad Bechara and Andrea Mantovani representing Alira Health on the agenda at World EPA Congress.
Market Access Pricing Real-World Evidence (RWE)
News January 24, 2024
Alira Health and AseBio Announce Market Access Mentoring Program for 2024
Alira Health and AseBio, the Spanish Bioindustry Association, are pleased to announce the 2024 edition of their market access mentoring program for AseBio members.
Biotech Market Access Spain Startups
Case Studies January 18, 2024
Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List
A pharma company with a blood disorder treatment needed support to submit a value dossier to the WHO to add a medicine to the Essential Medicines List.
Market Access Pharma
News January 18, 2024
Alira Health and Biocat Announce Startup Support Program for 2024
Alira Health and Biocat, a strategic stakeholder building the Catalan life sciences and ecosystem, partnered to foster Market Access for startups.
Market Access Startups
Events January 17, 2024
Presentation: Pilot Project for the Inclusion of the Patient Voices in the Regional Market Access Drug Committees in Spain
On January 23rd we will present the results of the first phase of the “Pilot Project for the Inclusion of the Patient Voices in the Regional Market Access Drug Committees in Spain.”
Market Access Patient Engagement Spain
Case Studies January 8, 2024
Pharma Company Extends to New Markets through Strategic Licensing Agreements
A Swedish pharma company saw a market opportunity to expand access to its proprietary product outside of the Nordics and sought support developing strategic licensing deals.
Market Access Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.